Welcome! Whether you are a potential investor in BioCryst Pharmaceuticals or you are already a shareholder, our investor center is the primary source of information about the company. Just choose a topic, or if you have a question, e-mail us.
Recent Releases View All Releases
Sep 26, 2016
BioCryst Closes $23 Million Senior Credit Facility
Cash runway extended to early 2018; Facility to be repaid with RAPIVAB revenues RESEARCH TRIANGLE PARK, N.C., Sept. 26, 2016 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, ...
Sep 7, 2016
BioCryst Announces Positive Study Results for BCX4430 Delayed Treatment of Ebola Virus Infection in a Non-Human Primate Model
RESEARCH TRIANGLE PARK, N.C., Sept. 07, 2016 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced positive results from a proof-of-concept study of it...
Rob Bennett, Vice President Investor Relations & Operations
For more information click here.
Questions about stock transfers and lost certificates should be directed to the transfer agent: